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Abstract

OPEN ACCESS

Hypertensive crisis is defined as severe hypertension with a blood pressure of
greater than 180/120 mmHg, and may be further classified as urgency or emergency.
Hypertensive urgency occurs over days to weeks, whereas hypertensive emergency
occurs in hours to days and the patient presents with evidence of end organ damage.
Patients of any age may present with hypertensive crisis, common etiologies include
undiagnosed hypertension, noncompliance with therapy or inadequate therapy. Timely
assessment of the patient is important and should include appropriate measurement
of blood pressure, a thorough history and physical, and laboratory testing to evaluate
for end organ damage. Antihypertensive agents utilized in the setting of hypertensive
emergency should be short acting and easy titratable, with examples including
labetalol, esmolol, nitroprusside, nitroglycerin, fenoldopam, and nicardipine. The
patient may be switched to oral therapy once there is stable blood pressure control
and there are no longer signs or symptoms of end organ damage. Selection of oral
therapy and goal blood pressure is dependent upon patient characteristics such as
age, race and co-morbidities.

Keywords

INTRODUCTION
Hypertension is a common chronic condition that affects
approximately 78,000,000 adults within the United States [1].
Hypertensive crisis is defined as severe hypertension with a blood
pressure of greater than 180/120 mmHg, and may be further
classified as urgency or emergency [2,3]. Hypertensive urgency
occurs in the setting of days to weeks and patients present most
commonly with a headache. Hypertensive emergency occurs
in hours to days and the patient presents with evidence of end
organ failure and severe headache. Signs and symptoms of end
organ failure are listed in (Table 1). An estimated 7% of patients
progress to hypertensive emergency prior to being prescribed
antihypertensive therapy and 1 to 2% will progress while treated
with anti-hypertensive therapy during their lifetime [2,4]. The
mortality rate, if hypertensive emergency remains untreated, at 1
and 5 years is 70 to 90% and 100% respectively.

CASE PRESENTATION

A 44 year old white male with a medical history positive
for hypertension presents to the emergency room with a chief
complaint of headache that started about three days ago, somewhat
lessened by aspirin. The onset is during light activity and has been
intermittent; it is still present upon admission. The patient has a
history of noncompliance, prescribed metoprolol tartrate 50mg
twice daily, and in checking with his pharmacy it is found that he has
not had his medication filled in over a month. The patient reports
a weight gain of 20 pounds over the past few years and complains
of excessive fatigue. Review of systems is unremarkable with the

• Hypertensive crisis
• Hypertensive emergency
• Hypertension
• Noncompliance

exception of complaints of headache. Physical exam reveals a blood
pressure of 200/120 mmHg in the right arm, 198/122 mmHg in the
left arm, and funduscopic exam reveals arteriovenous (A/V) nicking
and papilledema. Laboratory values are within normal limits except
for BUN 32 mg/dL and SrCr 2.4 g/dL.
Table 1: Potential findings of end-organ compromise 2,3.
System

Finding

Vital signs

Irregular pulse, blood pressure differential
and/or asymmetrical pulses (aortic
dissection)

Cardiovascular
Pulmonary
Renal
Neurologic
Ophthalmologic
Extremities

S3 heart sound (heart failure), acute chest
pain (myocardial infarction or aortic
dissection)
Jugular venous distension (heart failure),
carotid pulses
Dypsnea, pulmonary edema (crackles,
rhonchi, rales)

Oliguria or anuria, elevated serum creatinine
and blood urea nitrogen
Severe headache, dizziness, altered level of
consciousness, lateral gaze
Retinopathy, retinal hemorrhage,
papilledema, visual changes

Edema, diminished or delayed pulses
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DISCUSSION
Patients at any age may present with hypertensive emergency,
common
etiologies
include
undiagnosed
hypertension,
noncompliance with therapy or inadequate therapy [5].Clinically,
the patient would exhibit a blood pressure greater than 180/120
mmHg and target organ dysfunction. The patient in the case presents
with a blood pressure of 200/120 mmHg and signs of end organ
damage due to an elevated serum creatinine and an funduscopic
exam revealing A/V nicking and papilledema.

Timely assessment of a patient with hypertensive crisis is
important and should include appropriate measurement of blood
pressure, a thorough history and physical and specific testing for end
organ damage. The blood pressure should be checked in both arms
utilizing an appropriate size cuff so as to not cause false elevations
[6]. The cuff bladder must cover 80% of the arm circumference with
the patient seated and the arm supported at heart level.
The history and physical examination are crucial to provide
details regarding end organ damage. Patients with a history of
hypertension should be assessed for duration of the disease, baseline
blood pressure values and severity [2,5,7]. Additionally, a thorough
medication history should be performed, including both over-thecounter and prescription medications, to evaluate for therapies that
may precipitate a hypertensive crisis.

ANTI-HYPERTENSIVE AGENTS

The goal in hypertensive emergency is a reduction in MAP by
no more than 25% within the first hour, then reduce to 160/110 to
100 mmHg within the next 2 to 6 hours [8].There are several classes
of medications available for treatment of hypertensive emergency;
choice of therapy should be based upon end organ damage as
outlined in (Table 2) [2,3]. Patients with hypertensive emergency
will be admitted to the hospital and treated with intravenous therapy
as it is considered to be life-threatening. Preferred agents should
be short acting and easily titratable; examples include esmolol,
labetalol, nicardipine, fenoldopam, nitroglycerin and nitroprusside.
Esmolol and labetalol are both beta-adrenergic blocking agents
utilized in the treatment of hypertensive emergency [2,3,7]. The
antihypertensive effects of labetalol administered intravenously
begin within 2 to 5 minutes, and peak at 5 to 15 minutes. Labetalol
Table 2: Targeted therapies2,3,7.

lowers blood pressure by reducing peripheral vascular resistance
while maintaining cardiac output in contrast to esmolol which
lowers blood pressure by reducing cardiac output. Esmolol has an
onset of action within 60 seconds and duration of 10 to 20 minutes.
It should be used with caution in patients with chronic obstructive
lung disease and avoided in patients already on beta-blocker
therapy; patients with bradycardia and those with decompensate
heart failure [9].

Nicardipine is a second generation derivative calcium channel
blocker with a high vascular selectivity. It has an onset of action
between 5 to 15 minutes with duration of 4 to 6 hours and possesses
coronary and cerebral vasodilatory properties [10]. Fenoldopam
is a selective dopamine-1-receptor antagonist that reduces blood
pressure by its vasodilatory action of peripheral dopamine-1
receptors resulting in systemic and renal vasodilation. The onset
of action is within 5 minutes with a duration between 30 to 60
minutes [7,11]. Fenoldopam has efficacy in the setting of impaired
renal function as clinical evidence has shown an improvement in
creatinine clearance, renal blood flow and sodium excretion in
hypertensive patients [12]. Its use should be avoided in patients
with increased intraocular pressure and intracranial hypertension.

Sodium nitroprusside and nitroglycerin are effective in the
treatment of hypertensive emergency in specific scenarios. Sodium
nitroprusside is both an arterial and venous vasodilator with an
immediate onset and short duration of action. It should be used with
caution in patients with renal or liver dysfunction, cerebrovascular
accident and coronary artery disease. Sodium nitroprusside
contains 44% cyanide by weight that is released non-enzymatically
and metabolized in the liver to thiocyanate which is eliminated
renally [2,3,7]. Removal of the cyanide from the system is dependent
upon the availability of thiosulfate, required for metabolism from
cyanide to thiocyanate, renal function and liver function. Cyanide
accumulation may result in coma, encephalopathy, convulsions,
respiratory failure and irreversible neurological irregularities.
Thiocyanate toxicity manifests as psychosis, delirium and possible
hypothyroidism. Sodium nitroprusside should be reserved for
patients not responding to other IV antihypertensive agents due
to the potential toxicity. Nitroglycerin is a preload and after load,
at higher doses, reducing agent with efficacy in patients with acute
coronary syndrome or acute pulmonary edema presenting with
hypertensive emergency.

Medication

Population

Labetalol

Post-operative hypertension, Ischemic stroke, Hypertensive
encephalopathy, Acute cardiac ischemia, Eclampsia

Esmolol
Nicardipine

Fenoldopam

Sodium Nitroprusside
Nitroglycerin

Post-operative hypertension

Post-operative hypertension, Ischemic stroke, Hypertensive
encephalopathy, Acute renal failure, Eclampsia, Systolic heart
failure
Ischemic stroke, Hypertensive encephalopathy, Acute renal
failure, Systolic heart failure
Systolic heart failure

Acute cardiac ischemia with esmolol or labetalol
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Dosing
20 to 40mg IV q 30 min (max 300 mg/day)
2 mg/min continuous infusion (max 300 mg/
day)
500 mcg/kg load over 1 minute, infuse at 25 to
50 mcg/kg/min, titrate by 25 mcg/kg/min q
10 to 20 min (max 300 mcg/kg/min)
5 mg/hr, increase by 2.5 mg/hr q 5 to 15 min
(max 15 mg/hr)

0.1 to 0.3 mcg/kg/min, titrate by 0.1 mcg/kg/
min q 15 min (max 1.6 mcg/kg/min)
0.5 mcg/kg/min, titrate by 0.5 mcg/kg/min
(max 2 mcg/kg/min)
5 mcg/min, titrate by 5 mcg/min q 5 to 10 min
(max 60 mcg/min)
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MONITORING
Once therapy is initiated blood pressure should be measured
every 15 to 30 minutes to evaluate response to therapy [13].
Ongoing physical assessment, laboratory and diagnostic testing
should be performed during treatment to identify resolution of and
new-onset end organ damage. The patient may be switched to oral
therapy once the blood pressure is stable and there are no longer
signs or symptoms of end organ damage. Selection of oral therapy
and goal blood pressure is dependent upon patient characteristics
such as age, race and co-morbidities [14].

OUTPATIENT THERAPY

Current guideline recommendations are to initiate therapy
with a thiazide diuretic, dihydropyridine calcium channel blocker,
angiotensin converting enzyme inhibitor (ACE inhibitor) or
angiotensin receptor blocker (ARB) and titrate to a goal diastolic
blood pressure of less than 90 mmHg [14]. The preferred agent in
patients with diabetes mellitus and/or chronic kidney disease is
either an ACE inhibitor or ARB, and in African American patients
dihydropyridine calcium channel blocker or thiazide diuretic.
Otherwise, selection of agent is dependent upon medication allergies,
regimen, availability and cost. Patients should be monitored for
attainment of blood pressure goal monthly, if not at goal current
therapy dose should be increased or another antihypertensive
agent from a different class added to therapy. Blood pressure should
continue to be assessed until the patient reaches goal blood pressure.
If the patient is unable to reach goal on a two drug therapy regimen
at maximum therapeutic dose, a third antihypertensive medication
should be added to the regimen. Current recommendations are to
not prescribe the use of ACE inhibitors and ARBs simultaneously;
other medication classes of antihypertensive medication may be
prescribed to gain control of blood pressure if the patient requires
greater than a three drug regimen [14]. These include potassium
sparing diuretics, vasodilators and alpha agonists.

of 200/120 mmHg in the right arm, 198/122 mmHg in the left
arm and signs of acute kidney injury, but this is reversible with
appropriate management of the hypertensive crisis. The patient
was taking metoprolol tartrate at home, but current evidence no
longer supports beta-blocker therapy as a first-line in the treatment
of hypertension [14]. Appropriate therapy for this patient would be
initiation of amlodipine 5 mg daily with chlorthalidone 25 mg daily.
Acutely the patient was treated with the dihydropyridine calcium
channel blocker nicardipine, once the blood pressure is controlled
and there are no longer signs of end organ failure nicardipine may
be titrated off upon initiation of amlodipine. Initiation of dual
therapy is appropriate based upon the patient presenting with a
blood pressure of greater than 160/100 mmHg to reach his goal of
less than 140/90 mmHg [14].
Prior to discharge the patient should receive verbal and written
counseling on amlodipine and chlorthalidone. Recommendations
on purchase of home blood pressure monitoring devices should
be provided, along with instructions on how to appropriately
monitor at home [15] .These instructions should include selection
of appropriate arm cuff size, when to monitor, how often to monitor,
and what to do in situations of multiple elevated blood pressures.
The patient should be told to take multiple readings (up to 3 at one
minute intervals), monitor at the same time each day, and record and
bring measurement log to follow-up appointments [15]. He should
also receive counseling on noncompliance and the co-morbidities
associated with non- and under- treatment of hypertension. A study
by Saguner et al found that non adherence was the most important
factor associated with hypertensive crisis [16]. The study concluded
that improvement of medical adherence in antihypertensive therapy
would assist in preventing admissions for hypertensive crisis.
The pharmacist’s role initially begins with medication counseling
in the inpatient setting.
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